Bladder Cancer Drug Atezolizumab Proved To Be Effective As Initial Treatment The recently approved atezolizumab (brand name Tecentriq) showed to be promising as a first-option treatment for patients with advanced bladder cancer, according to new data presented Sunday. by Katrina Pascual
Healthy Living/Wellness New Drug Atezolizumab Shrinks Lung And Bladder Cancer Tumor Claims Roche by Rhodi Lee